Drug Pipeline

Cilostazol Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
4
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT06919835
CiLostAzol for pReventIon of Recurrent sTroke in Africa		 date change Primary completion moved earlier: 2028-07-01 -> 2027-08-01
Active Studies by Phase
Phase 4
2
Phase 3
1
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06757764 The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to… Cerebral Infarction Recruiting
NCT06402747 Clopidogrel Versus Cilostazol on Vessels Type 2 Diabetes Recruiting
Phase 3
NCT06919835 CiLostAzol for pReventIon of Recurrent sTroke in Africa Stroke Not Yet Recruiting
Phase 1/2
NCT03109288 Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of… Multiple Sclerosis Recruiting
Sponsors Running Cilostazol Trials
National Institute of Allergy and Infectious Diseases (NIAID) (1) Seoul National University Bundang Hospital (1) Asan Medical Center (1) Northern California Institute of Research and Education (1)
Disease Areas
Multiple Sclerosis (1) Type 2 Diabetes (1) Diabetes (1) Stroke (1)
Get alerts when Cilostazol trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free